US Physical Therapy (NYSE: USPH) reported Q3 EPS of $0.66, $0.01 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $197.13 million versus the consensus estimate of $194.05 million.

2025 EARNINGS GUIDANCE

Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million, reflecting third-quarter results and the Company’s current expectations for the remainder of the year.

For earnings history and earnings-related data on US Physical Therapy (USPH) click here.